# Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy

Source: https://onco.cc/trials/nct07669519/  
OnCo record `nct07669519` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Nuvastatic™ in colorectal cancer, run by Natureceuticals Sdn Bhd, now recruiting.

## Summary

Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy is a phase 3 interventional study registered as NCT07669519 by Natureceuticals Sdn Bhd, with 180 participants planned, started 2025-08-18 and due to reach its primary completion in 2027-03-31. Interventions recorded: Nuvastatic™ and Placebo.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07669519
- Phase: 3
- Setting: Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy
- Sponsor: Natureceuticals Sdn Bhd
- Enrolled: 180

## Sources

- ClinicalTrials.gov NCT07669519: https://clinicaltrials.gov/study/NCT07669519

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)

---
JSON: https://onco.cc/api/v1/entities/nct07669519.json